Sort
4,870 grants matching “glp 1”
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master
$430,335Lichun Lu · Mayo Clinic Rochester · R01 · FY2019 · AR
Regulators of Food Intake
$430,239Jonathan Krakoff · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Biobehavioral Prediction of Illness Trajectory in Bulimic Syndromes
$429,777Pamela K. Keel · Florida State University · R01 · FY2016 · MH
03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)
$429,752David Harlan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Cellular and Synaptic Hypothalamic Reorganization After Exercise Training
$429,303Kevin W Williams · Ut Southwestern Medical Center · P01 · FY2023 · DK
Paracrine regulation of islet cell function by primary cilia
$429,216Jing Wang Hughes · Washington University · R01 · FY2024 · DK
Insights into EHMT1 Variants in the Neurodevelopmental Disorder Kleefstra Syndrome through Structural Dynamics and Functional Analysis
$429,000Raul A Urrutia · Medical College Of Wisconsin · R21 · FY2024 · HD
An exploratory randomized controlled trial of the effects of oral semaglutide on alcohol craving and consumption
$429,000Joseph P Schacht · University Of Colorado Denver · R21 · FY2023 · AA
Stem cell proliferation / meiosis decision in C. elegans
$428,611Tim B. Schedl · Washington University · R01 · FY2006 · GM
Stem cell proliferation / meiosis decision in C. elegans
$428,533Tim B. Schedl · Washington University · R01 · FY2007 · GM
Stem cell proliferation / meiosis decision in C. elegans
$428,468Tim B. Schedl · Washington University · R01 · FY2008 · GM
Targeting chemoresistant prostate cancer with novel EED inhibitors
$428,304Daqing Wu · Clark Atlanta University · R01 · FY2025 · CA
Renal dopamine-1 receptor defect in hypertension
$428,076Pedro A. Jose · George Washington University · R01 · FY2019 · DK
Renal dopamine-1 receptor defect in hypertension
$428,076Pedro A. Jose · George Washington University · R01 · FY2020 · DK
Renal dopamine-1 receptor defect in hypertension
$428,076Pedro A. Jose · George Washington University · R01 · FY2018 · DK
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
$427,109Matthias G. Von Herrath · La Jolla Institute For Immunology · U01 · FY2007 · DK
A study of hormone-expressing taste cells: in vivo and in vitro
$427,030Josephine Earley · National Institute On Aging · ZIA · FY2019 · AG
Central GLP1 Signaling Pathways and Anxiety
$426,644Linda M Rinaman · Florida State University · R01 · FY2021 · MH
Central GLP1 Signaling Pathways and Anxiety
$426,644Linda M Rinaman · Florida State University · R01 · FY2023 · MH
Central GLP1 Signaling Pathways and Anxiety
$426,644Linda M Rinaman · Florida State University · R01 · FY2022 · MH
Mechanisms Underlying Predictors of Success from Obesity Surgery
$426,015Harry R Kissileff · Columbia University Health Sciences · R01 · FY2018 · DK
Serum markers of glucagon sensitivity in calorie restricted humans
$425,958Jennifer Helene Stern · University Of Arizona · R21 · FY2025 · AG
Neurohumoral Regulation in Diabetic Enteropathy
$424,958Adil E. Bharucha · Mayo Clinic Rochester · P01 · FY2014 · DK
Physiology and regulation of T2R bitter taste receptors in enteroendocrine cells
$424,125Timothy F Osborne · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · DK
Physiology and regulation of T2R bitter taste receptors in enteroendocrine cells
$424,125Timothy F Osborne · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · DK